Company

Nohla Therapeutics Inc.

Nohla Therapeutics develops cell therapies for hematology and oncology, aimed at patient recovery after stem cell transplants.

About

Nohla Therapeutics develops cell therapies for hematology and oncology, with a flagship therapy intended to help patients recover after stem cell transplants. Founded in 2015 and headquartered in Seattle, US, the company is at the Series B stage. It raised USD 11.000 mn on July 11, 2018 from Premier Partners, Schroders Capital and The University of Tokyo Edge Capital Partners.

3Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in